Statistics > Applications
[Submitted on 15 Aug 2016 (v1), last revised 2 Dec 2016 (this version, v2)]
Title:Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: meta-analyses of published studies
View PDFAbstract:Purpose: PFS is often used as a surrogate endpoint for OS in metastatic breast cancer studies. We have evaluated the association of treatment effect on PFS with significant HR$_{OS}$ (and how this association is affected by other factors) in published prospective metastatic breast cancer studies.
Methods: A systematic literature search in PubMed identified prospective metastatic breast cancer studies. Treatments effects on PFS were determined using hazard ratio (HR$_{PFS}$), increase in median PFS ($\Delta$MED$_{PFS}$) and % increase in median PFS (%$\Delta$MED$_{PFS}$). Diagnostic accuracy of PFS measures (HR$_{PFS}$, $\Delta$MED$_{PFS}$ and %$\Delta$MED$_{PFS}$) in predicting significant HR$_{OS}$ was assessed using receiver operating characteristics (ROC) curves and classification trees approach.
Results: Seventy-three cases (i.e., treatment to control comparisons) from 64 individual publications were identified for the analyses. Of these, 16 cases reported significant treatment effect on HR$_{OS}$ at 5% level of significance. Median number of deaths reported in these cases were 156. Area under the ROC curve (AUC) for diagnostic measures as HR$_{PFS}$, $\Delta$MED$_{PFS}$ and %$\Delta$MED$_{PFS}$ were 0.69, 0.70 and 0.75, respectively. Classification tree results identified %$\Delta$MED$_{PFS}$ and number of deaths as diagnostic measure for significant HR$_{OS}$. Only 7.9\% (3/39) cases with $\Delta$MED$_{PFS}$ shorter than 48.27\% reported significant HR$_{OS}$. There were 7 cases with $\Delta$MED$_{PFS}$ of 48.27\% or more and number of deaths reported as 227 or more -- of these 5 cases reported significant HR$_{OS}$.
Conclusion: %$\Delta$MED$_{PFS}$ was found as better diagnostic measure for significant HR$_{OS}$. Our analysis results also suggest that consideration of total number of deaths may further improve its diagnostic performance.
Submission history
From: Madan Kundu [view email][v1] Mon, 15 Aug 2016 15:16:56 UTC (50 KB)
[v2] Fri, 2 Dec 2016 02:37:12 UTC (43 KB)
Current browse context:
stat.AP
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
Connected Papers (What is Connected Papers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.